awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33628778-161FD82D-17DC-4538-8177-AEB4C2BD5DF8
Q33628778-161FD82D-17DC-4538-8177-AEB4C2BD5DF8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33628778-161FD82D-17DC-4538-8177-AEB4C2BD5DF8
Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426.
P31
Q33628778-161FD82D-17DC-4538-8177-AEB4C2BD5DF8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33628778-161FD82D-17DC-4538-8177-AEB4C2BD5DF8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
64128bf0c670748f79e5cf6b49d82ddecf6dcaf7
P31
scholarly article